HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Diisopropylethylamine → N-Boc-2-Methyl-Piperidine

HRID 1268602
Print

Reaction equation

HRID 1268602 reaction equation
Cl.CN(C)CCCN=C=NCC.O.ON1C2C=CC=CC=2N=N1.[C:24]([O:28][C:29]([N:31]1[CH2:36][CH2:35][CH:34](C(O)=O)[CH2:33][CH:32]1[CH3:40])=[O:30])([CH3:27])([CH3:26])[CH3:25].N[C@H](CC1C=CC2C(=CC=CC=2)C=1)C(N(C)[C@@H](C1ON=C(C)N=1)CC1C=CC2C(=CC=CC=2)C=1)=O.FC(F)(F)C([O-])=O.C(N(C(C)C)CC)(C)C>CN(C)C=O>[C:24]([O:28][C:29]([N:31]1[CH2:36][CH2:35][CH2:34][CH2:33][CH:32]1[CH3:40])=[O:30])([CH3:27])([CH3:25])[CH3:26]
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

8

Reactant 6

HCID 81531DiisopropylethylamineHCID 84468TrifluoroacetateHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 27960291-Hydroxybenzotriazole hydrateHCID 223270181-Boc-2-methylpiperidine-4-carboxylic Acid
HCID 53797289
(2R)-2-amino-N-methyl-N-[(1R)-1-(3-methyl-1,2,4-oxadiazol-5-yl)-2-(2-naphthyl)ethyl]-3-(2-naphthyl)propionamide

Product 1

HCID 4578077N-Boc-2-Methyl-Piperidine

Reagents, catalysts & solvents 1

HCID 6228DimethylformamideSolvent2×

Procedure

N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (0.46 g, 2.42 mmol) and 1-hydroxy-benzotriazole monohydrate(0.37 g, 2.41 mmol) were added to a solution of 2-methylpiperidine-1,4-dicarboxylic acid-1-tert-butylester (0.59 g, 2.42 mmol) in N,N-dimethylformamide (8 mL). After 30 min at 20° C. a solution of (2R)-2-amino-N-methyl-N-[(1R)-1-(3-methyl-1,2,4-oxadiazol-5-yl)-2-(2-naphthyl)ethyl]-3-(2-naphthyl)propionamide (as a trifluoroacetate) (1.0 g, 1.73 mmol) and diisopropylethylamine (0.22 g, 1.73 mmol) in N,N-dimethylformamide (4 mL) was added. After 18 h at 20° C. the reaction mixture was poured on water (100 mL) and extracted several times with ethyl acetate (total 60 mL). The collected organic phases were washed with aqueous citric acid (10%, 20 mL), a saturated solution of sodium hydrogen carbonate (20 mL) and water (3×20 mL). After drying (magnesium sulfate) the solution was concentrated in vacuo to give 1.25 g of crude 4-(1-{methyl-[1-(3-methyl-1,2,4-oxadiazol-5-yl)-2-(2-naphthyl)ethyl]carbamoyl}-2-(2-naphthyl)ethyl)-carbamoyl)-2-methylpiperidine-1-carboxylic acid tert-butyl ester that was used for the next step without further purification.

Workup

  1. additionAfter 18 h at 20° C. the reaction mixture was poured on water (100 mL)
  2. extractionextracted several times with ethyl acetate (total 60 mL)
  3. washThe collected organic phases were washed with aqueous citric acid (10%, 20 mL)
  4. dry with materialAfter drying (magnesium sulfate) the solution
  5. concentrationwas concentrated in vacuo

Sources & evidence

ORD record
ord-c9fe4e1fea6a446091a1e879be175ae5
Source dataset
uspto-grants-2003_04
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US06555570B2

Reaction notes

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes